# Next Generation Pediatric Neuroimaging (NGPN) Feasibility

> **NIH NIH R43** · CHAMPAIGN IMAGING, LLC · 2021 · $524,149

## Abstract

Pediatric MR imaging is especially difficult due to motion-related artifacts in the images. Often
this requires general anesthesia in the clinic, which has been shown recently to be
detrimental to brain development. This places unique barriers on assessment of this
population for both clinical and research purposes. In this application, we propose the
development of the Next Generation Pediatric Neuroimaging (NGPN) technology, which will
allow for high quality MR images to be collected in the presence of motion, thereby
eliminating the need for general anesthesia while imaging. This technology will provide the
MRI contrasts for proton density, T1, T2, T2*, diffusion, perfusion, and fMRI. The NGPN will
be achieved by the development of novel hardware (RF coils and T/R switches), imaging
sequences, and image reconstruction tools. These advancements will allow clinicians and
researchers to image pediatric subjects in a safer, more reliable and efficient manner.

## Key facts

- **NIH application ID:** 10149411
- **Project number:** 5R43MH122028-02
- **Recipient organization:** CHAMPAIGN IMAGING, LLC
- **Principal Investigator:** Curtis Andrew Corum
- **Activity code:** R43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $524,149
- **Award type:** 5
- **Project period:** 2020-05-01 → 2023-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10149411

## Citation

> US National Institutes of Health, RePORTER application 10149411, Next Generation Pediatric Neuroimaging (NGPN) Feasibility (5R43MH122028-02). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10149411. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*